Single Intravenous-dose Toxicity of Water-soluble Carthami-flos Pharmacopuncture (WCF) in Rats
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives: This study was performed to analyze the toxicity and to find the lethal dose of the test substance Water-soluble Carthami-flos pharmacopuncture (WCF) when used as a single intravenous-dose in 6-week-old, male and female Sprague-Dawley rats. Methods: The experiment was conducted at Biotoxtech according to Good Laboratory Practices. 20 female and 20 male Spague-Dawley rats were divided into 4 groups of 5 female and 5 male animals per group. The rats in the three experimental groups received single intravenous injections with 0.125-mL, 0.25-mL and 0.5-mL/animal doses of WCF, Groups 2, 3, and 4, respectively, and the control group, Group 1, received a single intravenous injection with a 0.5-mL dose of normal saline. Clinical signs were observed and body weight measurements were carried out for 14 days following the injections. At the end of the observation period, hematology, clinical chemistry, histopathological tests and necropsy were performed on the injected parts. Results: No deaths occurred in any of the groups. Also, no significant changes in body weight, hematological parameters or clinical chemistry test results between the control group and the experimental groups were observed. Visual inspection after necropsy showed no abnormalities. Histopathological tests on the injected parts showed no significant differences, except for Group 1 females; however, the result was spontaneous generation and had no toxicological meaning because it was not dose-dependent. Therefore, this study showed that WCF had no effect on the injected parts in terms of clinical signs, body weight, hematology, clinical chemistry, and necropsy. Conclusion: As a result of single intravenous-dose tests of the test substance WCF in 4 groups of rats, the lethal dose for both males and females exceeded 0.5 mL/animal. Therefore, WCF is a relatively safe pharmacopuncture that can be used for treatment, but further studies should be performed.
Abstract
Objectives: This study was performed to analyze the toxicity and to find the lethal dose of the test substance Water-soluble Carthami-flos pharmacopuncture (WCF) when used as a single intravenous-dose in 6-week-old, male and female Sprague-Dawley rats. Methods: The experiment was conducted at Biotoxtech according to Good Laboratory Practices. 20 female and 20 male Spague-Dawley rats were divided into 4 groups of 5 female and 5 male animals per group. The rats in the three experimental groups received single intravenous injections with 0.125-mL, 0.25-mL and 0.5-mL/animal doses of WCF, Groups 2, 3, and 4, respectively, and the control group, Group 1, received a single intravenous injection with a 0.5-mL dose of normal saline. Clinical signs were observed and body weight measurements were carried out for 14 days following the injections. At the end of the observation period, hematology, clinical chemistry, histopathological tests and necropsy were performed on the injected parts. Results: No deaths occurred in any of the groups. Also, no significant changes in body weight, hematological parameters or clinical chemistry test results between the control group and the experimental groups were observed. Visual inspection after necropsy showed no abnormalities. Histopathological tests on the injected parts showed no significant differences, except for Group 1 females; however, the result was spontaneous generation and had no toxicological meaning because it was not dose-dependent. Therefore, this study showed that WCF had no effect on the injected parts in terms of clinical signs, body weight, hematology, clinical chemistry, and necropsy. Conclusion: As a result of single intravenous-dose tests of the test substance WCF in 4 groups of rats, the lethal dose for both males and females exceeded 0.5 mL/animal. Therefore, WCF is a relatively safe pharmacopuncture that can be used for treatment, but further studies should be performed.
참고문헌 (16)
- Korean Pharmacopuncture Institute, "Pharmacopuncturology: principles and clinical applications", pp.128~145 (2012), Elsevier Korea LLC
- Yook TH., "Effects on the local thermal change following herbal acupuncture on D. I. T. I", The Acupuncture, 17(3), pp.57~68 (2000)
- Yoon MY., "Clinical study on effect of carthmi-flos herbal acupuncture therapy on osteoarthritis in knee joint", The Acupuncture, 19(2), pp.189~200 (2002)
- Lee HT., "Effect of cathami flos aqua-acupuncture on arthritis induced by injecting freund’s complete adjuvant", The Journal of East-West Medicine, 23(3), pp.6~20 (1998)
- Cho TS., "The effect of CF herbal acupuncture by oswestry disability index", J Pharmacopunct, 4(3), pp.15~20 (2001)
- 이형걸, "Single Intramuscular-dose Toxicity of Water soluble Carthmi-Flos herbal acupuncture (WCF) in Sprague-Dawley Rats", Journal of Pharmacopuncture, 17(1), pp.27~34 (2014), 대한약침학회[DOI]
- Kang KS., "Clinical studies on the cases of side effect of CF herbal acupuncture treatment", J Pharmacopunct, 4(2), pp.65~71 (2001)
- Joo HJ., "Research on pharmacopuncture", Daejeon. Korea Institute of Oriental Medicine, (5), pp.193~210 (1995)
- Korean Pharmacopuncture Institute., "Pharmacopuncturology: principles and clinical applications", pp.112~124 (2012), Korea LLC
- 최석우, "봉약침과 홍화약침으로 치료한 레이노 현상을 동반한 수근관증후군 환자 1례", Journal of Pharmacopuncture, 12(1), pp.103~108 (2009), 대한약침학회
- 김성욱, "紅花藥針이 局所腦血流量 및 平均血壓에 미치는 實驗的 影響", 대한침구의학회지, 21(2), pp.167~182 (2004), 대한침구의학회
- 오치석, "中脘에 施術한 紅花藥鍼이 抗癌 및 免疫機能에 미치는 影響", 대한침구의학회지, 21(5), pp.205~218 (2004), 대한침구의학회
- 안창석, "The Study on Acute and Subacute Toxicity and Sarcoma-180 Anti-cancer Effects of Carthami Tinctor-Fructus Herbal-acupuncture(CF)", Journal of Pharmacopuncture, 5(1), pp.7~26 (2002), 대한약침학회[DOI]
- 우동수, "홍화 약침액의 Nitric Oxide에 대한 소거효과", Journal of Pharmacopuncture, 10(2), pp.25~30 (2007), 대한약침학회
- 이종영, "경락약침의 윤제(CF, JsD)에 의한 부작용 사례보고", Journal of Pharmacopuncture, 10(3), pp.137~142 (2007), 대한약침학회
- Kim BW., "The side effect of lubricants pharmacopuncture in rat tissues", 13(1), pp.87~92 (2010)